CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

Search

Halma PLC

Closed

SectorIndustrials

3,612 2.44

Overview

Share price change

24h

Current

Min

3526

Max

3618

Key metrics

By Trading Economics

Income

107M

187M

Sales

651M

1.2B

P/E

Sector Avg

39.055

48.817

EPS

0.553

Dividend yield

0.67

Profit margin

15.096

Employees

9,000

EBITDA

184M

317M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.87% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.67%

2.06%

Market Stats

By TradingEconomics

Market Cap

-370M

13B

Previous open

3609.56

Previous close

3612

News Sentiment

By Acuity

10%

90%

14 / 408 Industrials

Halma PLC Chart

Past performance is not a reliable indicator of future results.

Related News

9 Feb 2026, 17:25 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 Feb 2026, 23:43 UTC

Market Talk

Gold Falls on Possible Technical Correction -- Market Talk

9 Feb 2026, 23:14 UTC

Market Talk

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 Feb 2026, 22:29 UTC

Market Talk

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 Feb 2026, 22:19 UTC

Market Talk

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 Feb 2026, 22:08 UTC

Market Talk

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 Feb 2026, 22:01 UTC

Earnings

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 Feb 2026, 21:59 UTC

Earnings

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 Feb 2026, 21:59 UTC

Earnings

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 Feb 2026, 21:58 UTC

Earnings

Friedman Industries 3Q Sales $168M >FRD

9 Feb 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

9 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Feb 2026, 21:48 UTC

Earnings

Friedman Industries 3Q EPS 43c >FRD

9 Feb 2026, 21:17 UTC

Earnings

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 Feb 2026, 21:13 UTC

Market Talk

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 Feb 2026, 21:04 UTC

Earnings

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 Feb 2026, 20:30 UTC

Market Talk

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 Feb 2026, 20:02 UTC

Market Talk

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 Feb 2026, 19:42 UTC

Market Talk

Japan's Yield Curve Expected to Flatten -- Market Talk

9 Feb 2026, 19:31 UTC

Market Talk

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 Feb 2026, 19:27 UTC

Market Talk

Gold Climbs Back Over $5,000/oz -- Market Talk

9 Feb 2026, 19:05 UTC

Market Talk

Nike Returns to List of Hottest Brands -- Market Talk

9 Feb 2026, 18:19 UTC

Market Talk

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 Feb 2026, 17:41 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 Feb 2026, 17:31 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 Feb 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

9 Feb 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Feb 2026, 17:17 UTC

Market Talk

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 Feb 2026, 17:16 UTC

Earnings

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Peer Comparison

Price change

Halma PLC Forecast

Price Target

By TipRanks

5.87% upside

12 Months Forecast

Average 3,756.25 GBX  5.87%

High 4,200 GBX

Low 2,490 GBX

Based on 13 Wall Street analysts offering 12 month price targets forHalma PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

7

Buy

5

Hold

1

Sell

Sentiment

By Acuity

14 / 408 Industrials

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat